Alexia Iasonos

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

Ethan Basch, Alexia Iasonos, Tiffani L. McDonough et al. · The Lancet Oncology · 2006 · 657 citations

Nursing, Oncology, Health Assessment +14

Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

Ethan Basch, Xiaoyu Jia, Glenn Heller et al. · JNCI Journal of the National Cancer Institute · 2009 · 627 citations

Pharmacy, Oncology, Clinical Epidemiology +16

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center

Nadeem R. Abu-Rustum, Kaled M. Alektiar, Alexia Iasonos et al. · Gynecologic Oncology · 2006 · 397 citations

Medicine, Oncology, Surgery +10

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Eli L. Diamond, Benjamin H. Durham, Gary A. Ulaner et al. · Nature · 2019 · 384 citations

Medicine, Cell Biology, Oncology +10

Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

Craig H. Moskowitz, Heiko Schöder, Julie Teruya‐Feldstein et al. · Journal of Clinical Oncology · 2010 · 326 citations · Full text

Medicine, Oncology, Radiology +14